QTL_RGD_ID	SPECIES	QTL_SYMBOL	QTL_NAME	CHROMOSOME_FROM_REF	LOD	P_VALUE	VARIANCE	FLANK_1_RGD_ID	FLANK_1_SYMBOL	FLANK_2_RGD_ID	FLANK_2_SYMBOL	PEAK_RGD_ID	PEAK_MARKER_SYMBOL	TRAIT_NAME	SUBTRAIT_NAME	TRAIT_METHODOLOGY	PHENOTYPES	ASSOCIATED_DISEASES	CURATED_REF_RGD_ID	CURATED_REF_PUBMED_ID	CANDIDATE_GENE_RGD_IDS	CANDIDATE_GENE_SYMBOLS	INHERITANCE_TYPE	RELATED_QTLS	RATMAP_ID	3.4_MAP_POS_CHR	3.4_MAP_POS_START	3.4_MAP_POS_STOP	3.4_MAP_POS_METHOD	3.1_MAP_POS_CHR	3.1_MAP_POS_START	3.1_MAP_POS_STOP	3.1_MAP_POS_METHOD	STRAIN_RGD_IDS	STRAIN_RGD_SYMBOLS	CROSS_TYPE	CROSS_PAIR
61324	rat	Eae5	Experimental allergic encephalomyelitis QTL 5	12	13.0			11051	D12Mit2	34925	D12Rat9			Brain/spinal cord inflammation	relapsing disease	inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with rats scored for degree of tail and limb paralysis on a nine point scale; relapsing disease is defined as more than one period of three-day increase in clinical score 	paresis	Multiple Sclerosis;Encephalomyelitis, Experimental Autoimmune	61031	10640775				Pia 4	44536	12	20932559	24470522	1 - by flanking markers	12	20922171	24333738	1 - by flanking markers	60997;61013	DA;E3	F2	E3 x DA
61325	rat	Aia5	Adjuvant induced arthritis QTL 5	10		0.01		61274	D10Arb20	61275	D10Arb22	10466	D10Mit1	Joint/bone inflammation	adjuvant induced	arthritis severity after adjuvant injection was measured via a cumulative scoring system for multiple joints; animals were evaluated twice a week for six weeks	joint swelling	Arthritis, Rheumatoid	625379	11953987				Cia3 and Pia5; reported to be the same as Aia3;Cia5	45641	10	24006429	110718848	2 - by one flank and peak markers	10	24007478	110733352	2 - by one flank and peak markers	61095;61114;631282	DA.F344(<i>Cia5</i>);DA/Bkl;DA.F344-(<I>D10Rat37-D10Arb22</I>)	Congenic	DA.F344 Congenic
61326	rat	Eae6	Experimental allergic encephalomyelitis QTL 6	1	5.3			34399	D1Mgh9	10951	D1Mit13	34326	D1Mgh21	Brain/spinal cord inflammation	change in body weight	experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status	paresis	Encephalomyelitis, Experimental Autoimmune;Multiple Sclerosis	61031;629561	10640775;11817600					44537	1	176854992	217991764	2 - by one flank and peak markers	1	176994239	186621913	1 - by flanking markers	60997;61013	DA;E3	F2	E3xDA;E3 x DA
61327	rat	Eae7	Experimental allergic encephalomyelitis QTL 7	1	5.6			33903	D1Mit7	10674	D1Mgh12	10445	D1Wox25	Brain/spinal cord inflammation	change in body weight	inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with animals scored for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status	paresis	Encephalomyelitis, Experimental Autoimmune;Multiple Sclerosis	61031;61039;629561	10640775;7537756;11817600					44538	1	240980142	247322277	1 - by flanking markers	1	241163531	247436752	1 - by flanking markers	60997;61013	DA;E3	F2	E3xDA;E3 x DA
61328	rat	Eae8	Experimental allergic encephalomyelitis QTL 8	19	4.0			11471	D19Mit9	34033	D19Mit5			Brain/spinal cord inflammation	acute disease	experimental autoimmune encephalomyelitis severity following injection with DA rat spinal cord homogenate was assayed daily; assay consists of scoring animals for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; acute disease is defined as a monophasic disease pattern in the assay over time	paresis	Multiple Sclerosis;Encephalomyelitis, Experimental Autoimmune	61031	10640775					44539	19	26534810	34998604	1 - by flanking markers	19	26539634	35003485	1 - by flanking markers	60997;61013	DA;E3	F2	E3 x DA
61329	rat	Eae9	Experimental allergic encephalomyelitis QTL 9	6	3.7			34098	D6Mgh3	35821	D6Rat10			Brain/spinal cord inflammation	change in body weight	inflammation severity was assayed daily following injection with DA rat spinal cord homogenate with animals scored for degree of tail and limb paralysis on a nine point scale with paralysis increasing from 0 to 8; change in body weight from day 7 to 40 was determined in association with disease status	paresis	Encephalomyelitis, Experimental Autoimmune;Multiple Sclerosis	61031	10640775					44540	6	127683728	147636619	4 - by one flank marker only	6	127687475	147642806	4 - by one flank marker only	60997;61013	DA;E3	F2	E3 x DA
61330	rat	Eau1	Experimental allergic uveoretinitis QTL 1	4		3.0E-4		11173	D4Arb8	34001	D4Mit17	11013	D4Arb7	Uvea inflammation score			eye inflammation;abnormal uvea morphology	Uveitis	61073;2293749;2296064	10323205;18281616;18453595	3197;3834	Npy;Tcrb		Cia3, Aia3, Iddm/Lyp, Scwia1	45703	4	69183301	134858710	1 - by flanking markers	4	69459431	135103551	1 - by flanking markers	60999;70509	LEW;F344/N	F2	LEWxF344
61331	rat	Eau2	Experimental allergic uveoretinitis QTL 2	12		5.0E-4		41960	D12Arb2	61278	D12Arb5	41960	D12Arb2	Uvea inflammation score			eye inflammation;abnormal uvea morphology	Uveitis	61073;2293749;2296064	10323205;18281616;18453595				Cia12, Pia4	45704	12	1	29130348	4 - by one flank marker only	12	0	28993736	4 - by one flank marker only	60999;70509	LEW;F344/N	F2	LEWxF344
61332	rat	Eau3	Experimental allergic uveoretinitis QTL 3	10		0.004		61279	D10Arb3	33941	D10Mit11	34053	D10Mit3	Uvea inflammation score			eye inflammation;abnormal uvea morphology	Uveitis	61073;2293749;2296064	10323205;18281616;18453595	2836;3395;3645;3772;3773;3774;3877;3967;61276;69069;1594396	Hsd17b1;Prkca;Ccl2;Stat3;Stat5a;Stat5b;Tnfaip1;Vtn;Crhr1;Ccl5;Trim25		Cia5, Oia3, Carrageenan, Pia10, Aia5, Atps2		10	35713452	101848683	1 - by flanking markers	10	35714501	101863126	1 - by flanking markers	60999;70509	LEW;F344/N	F2	LEWxF344
61428	rat	Scl3	Serum cholesterol level QTL 3	7	3.2		14.0	38334	D7Rat77	36442	D7Rat20	33729	D7Mit10	Lipid level	cholesterol		decreased circulating cholesterol level	Hypercholesterolemia	61092	10634822					45714	7	95054656	132141292	1 - by flanking markers	7	95088886	132217729	1 - by flanking markers	61103;61116	WKY;SHRSP/A3	F2	SHRSP/A3 x WKY
61429	rat	Cia17	Collagen induced arthritis QTL 17	18	4.6			10689	D18Mit5	41356	D18Rat82	41356	D18Rat82	Joint/bone inflammation	type II collagen induced		joint swelling	Arthritis, Rheumatoid	61067;2307198;2300074;1582387	11001927;18540828;18606636;16804090					45684	18	51166414	87265094	3 - by peak only	18	32494084	73739829	1 - by flanking markers	10003;60985	BBDR/Rhw;BN	F2	BB/DRxBN
61431	rat	Cia19	Collagen induced arthritis QTL 19	X	4.4			34192	DXMgh9	43947	DXWox3	34991	DXRat66	Joint/bone inflammation	type II collagen induced		joint swelling	Arthritis, Rheumatoid	61067;2307198;2300074;1582387	11001927;18540828;18606636;16804090				Cia18, Iddm	45686	X	1	88514313	2 - by one flank and peak markers	X	0	88587746	2 - by one flank and peak markers	10003;60985	BBDR/Rhw;BN	F2	BB/DRxBN
61432	rat	Cia1	Collagen induced arthritis QTL 1	20				11428	D20Wox3	40318	D20Rat60	11428	D20Wox3	Joint/bone inflammation	type II collagen induced	arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection	joint swelling	Arthritis, Rheumatoid	61062;2300074;1582387;2307198	8782824;18606636;16804090;18540828					32927	20	1	14605852	4 - by one flank marker only	20	3660872	14612758	1 - by flanking markers	61109;61114	F344/NHsd;DA/Bkl	F2	DA/Bkl x F344/NHsd
61434	rat	Cia3	Collagen induced arthritis QTL 3	4	4.8			10562	D4Arb21	61302	D4Arb24			Joint/bone inflammation	type II collagen induced	arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection	joint inflammation;joint swelling	Arthritis, Rheumatoid	61062;61068;2300074;1582387;2307198	8782824;9692888;18606636;16804090;18540828				Aia3, Pia5;Pia5	32929	4	104415843	149415843	4 - by one flank marker only	4	104660324	149660324	4 - by one flank marker only	61109;61114	F344/NHsd;DA/Bkl	F2	DA/Bkl x F344/NHsd
61435	rat	Cia4	Collagen induced arthritis QTL 4	7	5.3			10221	D7Arb17	34999	D7Rat44			Joint/bone inflammation	type II collagen induced	arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection	joint inflammation;joint swelling	Arthritis, Rheumatoid;Arthritis, Rheumatoid	61069;61062;61068;1599708;2300074;1582387;2307198	10398805;8782824;9692888;17277140;18606636;16804090;18540828	2896;3285	Il2rb;Pdgfrb	recessive	Cia8	32930	7	21202126	66202126	4 - by one flank marker only	7	21222856	66222856	4 - by one flank marker only	61109;61114	F344/NHsd;DA/Bkl	F2	DA/Bkl x F344/NHsd
61436	rat	Cia5	Collagen induced arthritis QTL 5	10	4.9			2686	Gh1	61275	D10Arb22			Joint/bone inflammation	type II collagen induced	arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection	joint inflammation;joint swelling	Arthritis, Rheumatoid	61062;61068;1642451;2300074;1582387	8782824;9692888;17673937;18606636;16804090	3395;61312	Prkca;Timp2		Aia5;Cia20, Cia21, Cia22, Cia23, Aia5	32931	10	95692240	110718848	4 - by one flank marker only	10	95708476	110733352	4 - by one flank marker only	61109;61114	F344/NHsd;DA/Bkl	F2	DA/Bkl x F344/NHsd
61437	rat	Cia6	Collagen induced arthritis QTL 6	8				34310	D8Mgh4	38898	D8Rat71	34068	D8Mgh11	Joint/bone inflammation	type II collagen induced		joint swelling	Arthritis, Rheumatoid	61067;1599708;2307198;2300074;1582387	11001927;17277140;18540828;18606636;16804090					45674	8	86627869	127907359	1 - by flanking markers	8	86647325	127927002	1 - by flanking markers	10003;60985	BBDR/Rhw;BN	F2	BB/DRxBN
61438	rat	Cia7	Collagen induced arthritis QTL 7	2	4.6	1.0E-4	20.0	11156	D2Mit24	33983	D2Mit23	33674	D2Mit17	Joint/bone inflammation	type II collagen induced	arthritis severity was measured via a scoring system for cartilage surface area and joint size; joints were measured twice weekly for six weeks following type II collagen injection	joint inflammation;joint swelling	Arthritis, Rheumatoid;Arthritis, Rheumatoid	61067;61063;2307198;2300074;1582387	11001927;9870869;18540828;18606636;16804090	2391	Cpb1	dominant		45675	2	59700886	146659672	1 - by flanking markers	2	59629119	146609712	1 - by flanking markers	10003;60985	BBDR/Rhw;BN	F2	BB/DRxBN
61439	rat	Cia8	Collagen induced arthritis QTL 8	7	5.1							36422	D7Rat26	Joint/bone inflammation	type II collagen induced		joint swelling	Arthritis, Rheumatoid	61069;2307198	10398805;18540828					44497									61109;61114	F344/NHsd;DA/Bkl	F2	DA/Bkl x F344/NHsd
